Identification of a metabolic signature to predict overall survival for colorectal cancer

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA A Cancer J Clin. 2019;69(1):7–34.
   PubMed Web of Science ®Google Scholar
• Punt CJA, Koopman M, Vermeulen L. From tumour heterogeneity to advances in precision treatment of colorectal cancer. Nat Rev Clin Oncol. 2017;14(4):235–246.
   PubMed Web of Science ®Google Scholar
• Rawla P, Sunkara T, Barsouk A. Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors. Prz Gastroenterol. 2019;14(2):89–103.
   PubMed Web of Science ®Google Scholar
• Cunningham D, Atkin W, Lenz HJ, et al. Colorectal cancer. Lancet. 2010;375(9719):1030–1047.
   PubMed Web of Science ®Google Scholar
• Kocarnik JM, Shiovitz S, Phipps AI. Molecular phenotypes of colorectal cancer and potential clinical applications. Gastroenterol Rep . 2015;3(4):269–276.
   Google Scholar
• Rodriguez-Salas N, Dominguez G, Barderas R, et al. Clinical relevance of colorectal cancer molecular subtypes. Crit Rev Oncol Hematol. 2017;109:9–19.
   PubMed Web of Science ®Google Scholar
• Kattan MW, Hess KR, Amin MB, Members of the AJCC Precision Medicine Core, et al. American Joint Committee on Cancer acceptance criteria for inclusion of risk models for individualized prognosis in the practice of precision medicine. CA Cancer J Clin. 2016;66(5):370–374.
   PubMed Web of Science ®Google Scholar
• Liu GM, Xie WX, Zhang CY, et al. Identification of a four-gene metabolic signature predicting overall survival for hepatocellular carcinoma. J Cell Physiol. 2020;235(2):1624–1636.
   PubMed Web of Science ®Google Scholar
• Wang Y, Hu F, Li JY, et al. Systematic construction and validation of a metabolic risk model for prognostic prediction in acute myelogenous leukemia. Front Oncol. 2020;10:540. DOI:10.3389/fonc.2020.00540.
   Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646–674.
   PubMed Web of Science ®Google Scholar
• La Vecchia S, Sebastián C. Metabolic pathways regulating colorectal cancer initiation and progression. Semin Cell Dev Biol. 2020;98:63–70.
   PubMed Web of Science ®Google Scholar
• Tan J, Wang HL, Yang J, et al. JMJD2B-induced amino acid alterations enhance the survival of colorectal cancer cells under glucose-deprivation via autophagy. Theranostics. 2020;10(13):5763–5777.
   PubMed Web of Science ®Google Scholar
• Wang R, Xiang W, Xu Y, et al. Enhanced glutamine utilization mediated by SLC1A5 and GPT2 is an essential metabolic feature of colorectal signet ring cell carcinoma with therapeutic potential. Ann Transl Med. 2020;8(6):302.
   PubMed Web of Science ®Google Scholar
• Wang Z, Zhang J. FOXP3 promotes colorectal carcinoma liver metastases by evaluating MMP9 expression via regulating S-adenosylmethionine metabolism. Ann Transl Med. 2020;8(9):592.
   PubMed Web of Science ®Google Scholar
• Yao J, Lei PJ, Li QL, et al. GLIS2 promotes colorectal cancer through repressing enhancer activation. Oncogenesis. 2020;9(5):57.
   PubMed Web of Science ®Google Scholar
• Balachandran VP, Gonen M, Smith JJ, et al. Nomograms in oncology: more than meets the eye. Lancet Oncol. 2015;16(4):e173–e180.
   PubMed Web of Science ®Google Scholar
• Lehuédé C, Dupuy F, Rabinovitch R, et al. Metabolic plasticity as a determinant of tumor growth and metastasis. Cancer Res. 2016;76(18):5201–5208.
   PubMed Web of Science ®Google Scholar
• Dayton TL, Jacks T, Vander Heiden MG. Vander Heiden MG. PKM2, cancer metabolism, and the road ahead. EMBO Rep. 2016;17(12):1721–1730.
   PubMed Web of Science ®Google Scholar
• He XD, Lei T, Li X, et al. PKM2 in carcinogenesis and oncotherapy. Oncotarget. 2017;8(66):110656–110670.
   PubMedGoogle Scholar
• Hsu MC, Hung WC. Pyruvate kinase M2 fuels multiple aspects of cancer cells: from cellular metabolism, transcriptional regulation to extracellular signaling. Mol Cancer. 2018;17(1):35.
   PubMed Web of Science ®Google Scholar
• Kuranaga Y, Sugito N, Shinohara H, et al. SRSF3, a splicer of the PKM gene, regulates cell growth and maintenance of cancer-specific energy metabolism in colon cancer cells. IJMS. 2018;19(10):E3012.
   Web of Science ®Google Scholar
• Sun Y, Luo M, Chang G, et al. Phosphorylation of Ser6 in hnRNPA1 by S6K2 regulates glucose metabolism and cell growth in colorectal cancer. Oncol Lett. 2017;14(6):7323–7331.
   PubMed Web of Science ®Google Scholar
• Pelosof L, Yerram S, Armstrong T, et al. GPX3 promoter methylation predicts platinum sensitivity in colorectal cancer. Epigenetics. 2017;12(7):540–550.
   PubMed Web of Science ®Google Scholar
• Ahn SB, Sharma S, Mohamedali A, et al. Potential early clinical stage colorectal cancer diagnosis using a proteomics blood test panel. Clin Proteom. 2019;16(1):34.
   PubMed Web of Science ®Google Scholar
• Lü B, Fang Y, Xu J, et al. Analysis of SOX9 expression in colorectal cancer. Am J Clin Pathol. 2008;130(6):897–904.
   PubMed Web of Science ®Google Scholar
• Bruun J, Kolberg M, Nesland JM, et al. Prognostic significance of β-catenin, E-cadherin, and SOX9 in colorectal cancer: results from a large population-representative series. Front Oncol. 2014;4:118.
   PubMedGoogle Scholar
• Prevostel C, Blache P. The dose-dependent effect of SOX9 and its incidence in colorectal cancer. Eur J Cancer. 2017;86:150–157.
   PubMed Web of Science ®Google Scholar
• Shi Z, Chiang CI, Mistretta TA, et al. SOX9 directly regulates IGFBP-4 in the intestinal epithelium. Am J Physiol Gastrointest Liver Physiol. 2013;305(1):G74–G83.
   PubMed Web of Science ®Google Scholar
• Zalzali H, Naudin C, Bastide P, et al. CEACAM1, a SOX9 direct transcriptional target identified in the colon epithelium. Oncogene. 2008;27(56):7131–7138.
   PubMed Web of Science ®Google Scholar
• Bushey RT, Dluzen DF, Lazarus P. Importance of UDP-glucuronosyltransferases 2A2 and 2A3 in tobacco carcinogen metabolism. Drug Metab Dispos. 2013;41(1):170–179.
   PubMed Web of Science ®Google Scholar
• Wang S, Zhang C, Zhang Z, et al. Transcriptome analysis in primary colorectal cancer tissues from patients with and without liver metastases using next-generation sequencing. Cancer Med. 2017;6(8):1976–1987.
   PubMed Web of Science ®Google Scholar
• Nilsson R, Jain M, Madhusudhan N, et al. Metabolic enzyme expression highlights a key role for MTHFD2 and the mitochondrial folate pathway in cancer. Nat Commun. 2014;5:3128.
   PubMed Web of Science ®Google Scholar
• Kohnz RA, Mulvihill MM, Chang JW, et al. Activity-based protein profiling of oncogene-driven changes in metabolism reveals broad dysregulation of PAFAH1B2 and 1B3 in cancer. ACS Chem Biol. 2015;10(7):1624–1630.
   PubMed Web of Science ®Google Scholar
• Chang JW, Zuhl AM, Speers AE, et al. Selective inhibitor of platelet-activating factor acetylhydrolases 1b2 and 1b3 that impairs cancer cell survival. ACS Chem Biol. 2015;10(4):925–932.
   PubMed Web of Science ®Google Scholar
• Cao W, Liu N, Tang S, et al. Acetyl-coenzyme A acyltransferase 2 attenuates the apoptotic effects of BNIP3 in two human cell lines. Biochim Biophys Acta. 2008;1780(6):873–880.
   PubMed Web of Science ®Google Scholar
• Röhrig F, Schulze A. The multifaceted roles of fatty acid synthesis in cancer. Nat Rev Cancer. 2016;16(11):732–749.
   PubMed Web of Science ®Google Scholar
• Santos CR, Schulze A. Lipid metabolism in cancer. Febs J. 2012;279(15):2610–2623.
   PubMed Web of Science ®Google Scholar
• Guo H, Zeng W, Feng L, et al. Integrated transcriptomic analysis of distance-related field cancerization in rectal cancer patients. Oncotarget. 2017;8(37):61107–61117.
   PubMedGoogle Scholar
• Sinkala M, Mulder N, Patrick Martin D. Metabolic gene alterations impact the clinical aggressiveness and drug responses of 32 human cancers. Commun Biol. 2019;2:414.
   PubMed Web of Science ®Google Scholar
• Peng X, Chen Z, Farshidfar F, Cancer Genome Atlas Research Network, et al. Molecular characterization and clinical relevance of metabolic expression subtypes in human cancers. Cell Rep. 2018;23(1):255–269.e4.
   PubMed Web of Science ®Google Scholar